Nature Communications (Nov 2019)

Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection

  • Francisco Caiado,
  • Diogo Maia-Silva,
  • Carolina Jardim,
  • Nina Schmolka,
  • Tânia Carvalho,
  • Cláudia Reforço,
  • Rita Faria,
  • Branka Kolundzija,
  • André E. Simões,
  • Tuncay Baubec,
  • Christopher R. Vakoc,
  • Maria Gomes da Silva,
  • Markus G. Manz,
  • Ton N. Schumacher,
  • Håkan Norell,
  • Bruno Silva-Santos

DOI
https://doi.org/10.1038/s41467-019-12983-z
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 15

Abstract

Read online

The development of post-chemotherapy resistance is a significant issue in the management of AML. Here, Caiado et al. suggest that the issue might be circumvented via upfront combination with hypomethylating agents that shape the clonal dynamics and transcriptional landscape of relapsing AML